Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

MAGICL TM (CLIA)

Getein Biotech, Inc. · 🇨🇳 China
Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06954414798746
Basic UDI-DI Code
B-06954414798746
Reference
/
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market
Manufacturer
Getein Biotech, Inc.

Additional Description

MAGICL TM (CLIA) is intended for the in vitro quantitative determination of Thrombomodulin (TM) in human plasma and whole blood. Clinically, It is mainly used to thrombosis risk assessment, auxiliary diagnosis of patients with thrombosis, therapeutic effect monitoring and recurrence risk assessment. For professional use only.

CND Nomenclature Codes

Code Description
W0103020405 ß-THROMBOGLOBULIN

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all